Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - Sorrento Therapeutics, Inc. | d604186d8ka.htm |
| EX-99.2 - EX-99.2 - Sorrento Therapeutics, Inc. | d604186dex992.htm |
| EX-99.3 - EX-99.3 - Sorrento Therapeutics, Inc. | d604186dex993.htm |
| EX-99.1 - EX-99.1 - Sorrento Therapeutics, Inc. | d604186dex991.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We agree to the inclusion as Exhibit 99.1 in this Current Report on Form 8-K/A filed September 30, 2013 of our report, dated April 22, 2013, on our audit of financial statements of IgDraSol, Inc. as of December 31, 2012 and for the period from May 17, 2012 (inception) to December 31, 2012.
/s/ Kelly & Company
Kelly & Company
Costa Mesa, California
September 30, 2013